Reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) often generates partially reprogrammed iPSCs (pre-iPSCs), low-grade chimera forming iPSCs (lg-iPSCs) and fully reprogrammed, high-grade chimera production competent iPSCs (hg-iPSCs). Lg-iPSC transcriptome analysis revealed misregulated Dlk1-Dio3 cluster gene expression and subsequently the imprinting defect at the Dlk1-Dio3 locus. Here, we show that germ-cell marker Dppa3 is present only in lg-iPSCs and hg-iPSCs, and that induction with exogenous Dppa3 enhances reprogramming kinetics, generating all hg-iPSCs, similar to vitamin C (Vc). Conversely, Dppa3-null fibroblasts show reprogramming block at pre-iPSCs state and Dlk1-Dio3 imprinting defect. At the molecular level, we show that Dppa3 is associated with Dlk1-Dio3 locus and identify that Dppa3 maintains imprinting by antagonizing Dnmt3a binding. Our results further show molecular parallels between Dppa3 and Vc in Dlk1-Dio3 imprinting maintenance and suggest that early activation of Dppa3 is one of the cascades through which Vc facilitates the generation of fully reprogrammed iPSCs.
P luripotent stem cells boast the differentiation potential virtually into any cell type of the body, and hence hold a great promise for regenerative medicine applications 1 . Recent advances in reprogramming strategies unveiled the induction of pluripotency in somatic cells by using few transcription factors resulting in the generation of induced pluripotent stem cells (iPSCs) 2, 3 . Reprogramming of mouse somatic cells into iPSCs often generates partially reprogrammed iPSCs (pre-iPSCs), low-grade iPSCs (lg-iPSCs) that produce only low-grade chimeras and completely reprogrammed, high-grade iPSCs (hg-iPSCs) that support high-grade chimerism [4] [5] [6] [7] [8] . Pre-iPSCs are characterized by the lack of endogenous pluripotency markers expression and show residual expression of reprogramming factors, absence of chimera formation and defects at the genetic and epigenetic level [4] [5] [6] [7] . Lg-iPSCs are morphologically indistinguishable from hg-iPSCs; however, they show abnormal hypermethylation of the imprinted Dlk1-Dio3 locus and contribute to low-grade chimeras with or without germline transmission 8, 9 . The transcriptome analysis of lg-iPSCs in comparison to embryonic stem cells (ESCs) revealed that the expression of coding and non-coding genes encoded by the Dlk1-Dio3 imprinting cluster is misregulated due to the aberrant acquisition of DNA methylation at the maternal allele along with the normally methylated paternal allele 8 . Recently, addition of vitamin C (Vc) during reprogramming was shown to result in iPSCs with normal Dlk1-Dio3 imprinting, yet the factor expressed in a Vc-dependent manner was not identified 10 .
Genomic imprinting is an epigenetic phenomenon established during gametogenesis and involves differential DNA methylation and post-translational histone modifications. Short DNA sequences called imprinting control regions (ICRs) are methylated on either the maternal or paternal allele to regulate expression of the imprinted gene in cis 11 . These marks lead to exclusive or preferential parent-specific monoallelic expression of imprinted genes 12, 13 . During embryonic development, a pool of primordial germ cells (PGCs) gives rise to progenitors of adult gametes. After their specification and up on their arrival at the genital ridge, these PGCs undergo demethylation of the whole genome including an erasure of parent-specific methylation marks of imprinted genes, the so-called imprints 14 . The reestablishment of genomic imprinting in germ cells (GCs) according to the sex of the embryo is initiated after the entry of PGCs into gonads and continues through germ-cell differentiation 15, 16 .
The imprint acquisition according to the sex of the embryo is regulated by several components, such as primary sequence specificity, chromatin configuration, non-histone proteins and transcriptional events (reviewed by Arnaud 17 ). Specifically, the de novo DNA methyltransferase Dnmt3a and its related protein Dnmt3l that has no methyltransferase activity, were shown to be essential for imprint establishment at several imprinted loci [18] [19] [20] . In addition to the DNA methylation machinery, several other DNA-binding proteins, such as Zfp57, Nlrp2, Nlrp7, Ctcfl and Prmt7, are implicated in the establishment of imprints in a sexspecific manner [21] [22] [23] [24] [25] . Once established in GCs, several factors are known to faithfully maintain and transmit the imprints during the early stages of embryogenesis to all somatic lineages (reviewed by Arnaud 17 ). Dppa3/PGC7 is one such factor expressed mainly in GCs and known to protect some of the maternal as well as paternal imprints during the wave of DNA demethylation occurring in early embryogenesis 26 .
Previously, we have shown that GC marker genes, such as Blimp1, Fragilis and Dppa3, are expressed in all pluripotent cell types and emerge early during somatic cell reprogramming into iPSCs 27 . In the present study, we evaluate whether these GC marker genes, in particular Dppa3, play any role in the maintenance of Dlk1-Dio3 imprinting during the generation of iPSCs. Interestingly, Dppa3 is expressed only in lg-iPSCs and hgiPSCs, but not in pre-iPSCs. Reprogramming studies in the presence of Dppa3, in addition to classical reprogramming factors (OSKM), show that supplementation of Dppa3 enhances reprogramming kinetics and generates all hg-iPSCs. In line with these observations, reprogramming studies with Dppa3-knock out (Dppa3-KO) fibroblasts reveal a reprogramming arrest in preiPSC state along with Dlk1-Dio3 imprinting defect. At the molecular level, we observe that Dppa3 is required for the suppression of virus-mediated reprogramming factors and endogenous retroviral elements (ERVs). Furthermore, Dppa3 is found to be associated with the intergenic differentially methylated region (IG-DMR) of the Dlk1-Dio3 and to counteract the binding of Dnmt3a to this region during reprogramming.
Results
Dppa3 is present in lg-iPSCs and hg-iPSCs, not in pre-iPSCs. Advances in understanding the process of somatic cell reprogramming towards iPS cells have proposed three phases in reprogramming: initiation, marking mesenchymal-to-epithelial transition; maturation and stabilization, with pre-iPSCs and characterized by silencing of exogenous reprogramming factors and activation of endogenous pluripotency-related genes, such as Dppa3, Sox2 and Dnmt3l 7 (Fig. 1a) . Progression through these phases generates fully reprogrammed hg-iPSCs, while failure to undergo the faithful reprogramming process yields pre-iPSCs or lg-iPSCs with imprinting defect at the Dlk1-Dio3 locus 4, [6] [7] [8] [9] . However, the molecular mechanisms and the determining factor(s) of these cell states are yet to be identified.
To decipher the cause of aberrant Dlk1-Dio3 imprinting, we established several iPSC lines from mouse embryonic fibroblasts (MEFs) using the classical Yamanaka's method 3 . We found clones (iPSC-1 and -2) that displayed mRNA expression of Gtl2 (also known as Meg3), a maternally expressed non-coding transcript from the imprinted Dlk1-Dio3 locus, above the threshold level typically found in ESCs (Gtl2 on ) 8 , and other clones (iPSC-3, -4, -5 and -6) that showed Gtl2 mRNA expression below that level (Gtl2 off ) (Fig. 1b) . Consistent with the expression pattern of Gtl2, iPSC-1 and -2 showed normal, 40-60% DNA methylation at the Dlk1-Dio3 IG-DMR, whereas the other clones showed DNA hypermethylation (Fig. 1c) . Then we analysed the mRNA expression of pluripotency-related genes in all six iPSC lines and detected no expression in iPSC-3 and -4, but similar expression levels to control were found in iPSC-1, -2, -5 and -6 (Fig. 1d) . These results led us to conclude that iPSC-1 and -2 are fully reprogrammed iPSCs, while iPSC-3 and -4 are in pre-iPSC state and iPSC-5 and -6 are in lg-iPSC state.
Recently, we showed that the expression of Dppa3/PGC7, a GC marker gene, precedes the expression of endogenous pluripotency marker genes, such as Oct3/4, Sox2, Nanog and Klf4, during somatic cell reprogramming 27 . Dppa3 is known to protect some maternal as well as paternal imprints during the first wave of DNA demethylation occurring in early embryogenesis and was also implicated in the regulation of DNA methylation at ERVs, such as intracisternal A-particles (IAPs) 26 . To determine whether Dppa3 functions in establishment/maintenance of Dlk1-Dio3 imprinting during somatic cell reprogramming, we analysed iPSC colonies for the Dppa3 RNA and protein expression. The expression of Dppa3 was observed both in lg-iPSCs and hgiPSCs, but not in pre-iPSCs (Fig. 1d,e) . In line with these results, protein expression analysis of two Gtl2 off (R21-5-OFF and 159-3-OFF) clones and one Gtl2 on clone (R-21-4-ON) from the study of Stadtfeld et al. 8 , detected the expression of Dppa3 in all the three clones, indicating that the Gtl2 off clones from their study might be lg-iPSCs ( Supplementary Fig. 1a ). To check if Dppa3-deficient ESCs 26 show any imprinting defect at the Dlk-Dio3 locus, we performed RNA expression analysis for Gtl2 and Dlk1 and found no obvious differences in their expression levels between Dppa3-deficient and control ESCs (Supplementary Fig. 1b) . Further, DNA methylation analysis of the Dlk1-Dio3 IG-DMR revealed no significant differences with B50% methylation levels in Dppa3-deficient and control ESCs ( Supplementary  Fig. 1c ). One imprinted paternally methylated locus, H19, was hypermethylated in both ESC types, whereas another, Rasgrf1, showed 40-57% methylation in control and hypomethylation in Dppa3-deficient, ESCs (Supplementary Fig. 1c ).
Dppa3 enhances reprogramming and generates all hg-iPSCs.
To analyse the effect of exogenous Dppa3 expression on maintenance of Dlk1-Dio3 imprinting, we reprogrammed Nanog-EGFP MEFs with Dppa3 (D) and Yamanaka factors (OSKM). OSKM þ D-transduced MEFs formed colonies already by day 8 and activated Nanog-EGFP by day 14 of reprogramming, whereas OSKM-only-transduced cells formed colonies only by day 12 and were EGFP-positive by day 18 (Fig. 2a,b) . OSKM þ D transduction greatly enhanced the number of alkaline phosphatase (AP)-and EGFP-positive colonies (Fig. 2c) ARTICLE OSKM-only generated Gtl2 off colonies exclusively (Fig. 2d) . The Dlk1-Dio3 IG-DMR showed moderate hypomethylation in OSKM þ D Gtl2 on and hypermethylation in OSKM-only-derived Gtl2 off , iPSCs (Fig. 2e) . To confirm Dppa3-mediated maintenance of Dlk1-Dio3 imprinting, we generated additional OSKM þ D clones. All were Gtl2 on ( Supplementary Fig. 2a ) and expressed paternally expressed Dlk1 ( Supplementary Fig. 2b ) and several Dlk1-Dio3 cluster-encoded miRNAs (Supplementary Fig. 2c -e) at ESC-comparable levels. We further confirmed AP, Nanog-EGFP and pluripotency marker genes expression in several OSKM þ D clones ( Supplementary Fig. 2f,g ). These clones generated teratomas consisting of all three germ-layer derivatives and chimeras with germline transmission (Fig. 2f,g ). Genotyping of F1 progeny confirmed the presence of OSKM þ D constructs ( Supplementary Fig. 3 ). Next, we investigated whether Dppa3 can replace any of the reprogramming factors during iPSCs generation. MEFs supplemented with Dppa3, replacing any Yamanaka factor, failed to generate iPSCs ( Supplementary Fig. 4 ), suggesting that Dppa3 cooperates with other reprogramming factors, but cannot drive reprogramming if any are lacking. Modified StemPro medium generates exclusively Gtl2 on iPSCs.
During the course of this study, we investigated whether StemPro-based low-serum medium (SPVc), which we regularly use for the culture of spermatogonial stem cells 28 , can generate all Gtl2 on iPSCs with greater efficiency. To this end, we reprogrammed Nanog-EGFP MEFs with OSKM in SPVc medium and found ESC-like colonies already by day 6 of reprogramming that finally resulted in a two-fold increase in AP-and Nanog-EGFP-positive colonies (Fig. 3a,b) . All SPVc-derived lines analysed were Gtl2 on ( Fig. 3c ) and expressed maternally expressed miRNAs, validating activation of Dlk1-Dio3 locus genes (Fig. 3d) . These results led us to hypothesize that the components of SPVc help in proper maintenance of imprinting at the Dlk1-Dio3 locus during reprogramming. The SPVc medium inherently contains Vc that was reported to protect against the loss of Dlk1-Dio3 imprinting during reprogramming 10 . It was shown that Vc functions primarily by preserving active chromatin structure at the Dlk1-Dio3 locus and by preventing recruitment of Dnmt3a, a de novo DNA methyltransferase, to this locus. Hence, we asked whether StemPro-based low-serum medium depleted of Vc (SP) can also generate exclusively Gtl2 on iPSCs with reprogramming kinetics similar to SPVc. However, the use of SP medium resulted in 
Percentage of Gapdh/Hprt mRNA 1.5 (Fig. 3b,e) .
Dppa3-deficient fibroblasts arrest in pre-iPSC state. On the basis of parallels between Dppa3 and Vc in preventing Dlk1-Dio3 imprinting loss, we investigated whether Vc treatment compensates for the Dppa3 absence during reprogramming. Towards this end, we reprogrammed MEFs derived from the Dppa3-knockout (KO)/ Oct4-EGFP animals (KO_MEFs) (Supplementary Fig. 5 ) in the presence and absence of Vc and in the presence of exogenous Dppa3. Reprogramming of KO_MEFs with OSKM-only resulted in iPSC-like colonies that, however, failed to activate the Oct3/4-driven EGFP, whereas cells reprogrammed with OSKM þ Vc or OSKM þ D showed efficient activation of the Oct3/4-EGFP (Fig. 4a) . The mRNA expression analysis for pluripotency marker genes revealed that KO_MEFs reprogrammed with OSKM-only (iPSC_K4) are arrested in the pre-iPSC state, as they could not activate the endogenous pluripotency network, whereas the cells reprogrammed with OSKM þ Vc (iPSC_KV) or OSKM þ D (iPSC_K5) showed expression levels comparable to control cells (Fig. 4b) . Silencing of exogenous reprogramming factors is crucial for proper transition from maturation-to-stabilization phase during the reprogramming and transition failure results in loss of endogenous pluripotency network activation 6 . Interestingly, OSKMonly-reprogrammed cells failed to inactivate viral transgenes, as indicated by higher levels of total Oct3/4 mRNA levels derived from the transgene (Fig. 4b) . iPSC_K4 clones showed very low Gtl2 mRNA levels and IG-DMR hypermethylation, whereas clones derived from OSKM þ Vc (iPSC_KV) or OSKM þ D (iPSC_K5) conditions showed normal Gtl2 expression and methylation (Fig. 4c,d) . The DNA methylation analysis of two additional imprinted loci, H19 and Snrpn, showed normal DNA methylation levels in iPSC clones form all three conditions ( Supplementary  Fig. 6a,b) , indicating that Dppa3 depletion specifically affects the Dlk1-Dio3 imprinting. It is known that Dppa3 suppresses ERVs such as IAPs and LINEs during early embryogenesis 26 . To determine whether ERVs are suppressed in iPSCs derived from Dppa3-KO fibroblasts, we performed quantitative reverse transcription PCR (qRT-PCR) analysis for their expression and found that IAPs are significantly activated in OSKM-only, but not in OSKM þ Vc or OSKM þ D, iPSCs (Fig. 4e) .
To verify whether Vc functions in conversion of pre-iPSCs derived from KO_MEFs towards lg-iPSCs or hg-iPSCs, we cultured these cells with Vc and could observe the activation of Oct3/4-EGFP (Fig. 4f) . These colonies resembled lg-iPSCs and showed no Gtl2 expression at a global level (data not shown), suggesting that Vc can overcome the reprogramming block, but cannot restore the imprinting defect in the resulting lg-iPSCs. To determine whether exogenous Dppa3 can rescue the reprogramming block seen in KO_MEFs-derived pre-iPSCs, we supplemented these clones with retroviral Dppa3 and observed neither Gtl2 activation nor morphological changes ( Supplementary Fig. 7a-c) .
Vitamin C (Vc) mediates early activation of Dppa3. We hypothesized that Vc might activate Dppa3, which is ultimately responsible for maintenance of proper imprinting during early stages of reprogramming. To verify this hypothesis, we reprogrammed Nanog-MEFs using OSKM in standard ESC medium in the presence or absence of Vc and investigated changes in chromatin modifications and pluripotency marker expression. After day 5 of reprogramming, MEFs treated with Vc ( þ Vc) showed enrichment for H3K4me3, a histone modification mark associated with active gene transcription, whereas MEFs treated without Vc ( À Vc) showed basal H3K4me3 levels (Fig. 5a,b) .
In (Fig. 5a,b) . These changes were also evident at day 7 of reprogramming ( Fig. 5a,b) . Endogenous Oct3/4 and Sox2 mRNA expression was activated at least two days earlier in þ Vc than in À Vc cells (Fig. 5c) . Further, by day 12 of reprogramming, we observed much higher levels of endogenous Oct3/4 and Sox2 mRNA levels in þ Vc cells compared with À Vc cells (Fig. 5c) . Surprisingly, Dppa3 mRNA expression was already detected by day 2 of reprogramming in þ Vc treated MEFs, but only by day 6 of reprogramming in control À Vc cells (Fig. 5c) . Correlating early Dppa3 activation with potential Vc-induced chromatin changes, we hypothesized that exogenous reprogramming factor(s) might gain access to the Dppa3 promoter and activate its expression early in Vc-treated cells. To ascertain this assumption, we searched publicly available chromatin immunoprecipitation (ChIP)-Seq data for Oct3/4-and Sox2-binding sites/ targets across the ESC genome (http://promotion.molgen.mpg.de/ gb2/gbrowse/Mm.enhancer/) and found Oct3/4 and Sox2 binding sites at the Dppa3 promoter region 29 (Fig. 5d) . To validate these global ChIP-Seq data, we performed ChIP assays with anti-Oct3/ 4 and anti-Sox2 antibodies and quantitative PCR (qPCR) analysis of two PCR amplicons in the Dppa3 promoter region. The qPCR data clearly showed that Oct3/4 and Sox2 bind Dppa3 promoter region (Fig. 5e ).
Dppa3 binds to the IG-DMR of the Dlk1-Dio3 cluster. Dppa3 is considered as a DNA-binding protein and indeed in vitro studies have shown that it binds DNA non-specifically 26 . To test the hypothesis that Dppa3 is physically associated with the IG-DMR of the Dlk1-Dio3 region, we performed ChIP assay with Dppa3 antibody and ESC chromatin. As the IG-DMR spans around 4.2 kb in the Dlk1-Dio3 cluster, we designed eight PCR amplicons (P1-P8) covering the entire region (Fig. 6a) . ChIP assays revealed that Dppa3 specifically binds the IG-DMR region represented by amplicons P2 and P3 (Fig. 6b) . Recent data showed that Dnmt3a is highly enriched at the IG-DMR during somatic cell reprogramming; probably leading to the silencing of maternal allele and that this effect can be counteracted by the addition of Vc 10 . This led us to analyse whether exogenous Dppa3 can also counteract Dnmt3a binding at the IG-DMR. Interestingly, Dnmt3a association with P2 and P3 was significantly reduced in OSKM þ D-transduced cells on day 9 of reprogramming, whereas OSKM-only-transduced cells showed Dnmt3a enrichment (Fig. 6c) . Similar results were obtained at day 12 of reprogramming ( Fig. 6d) , confirming that Dppa3 prevents IG-DMR hypermethylation by preventing Dnmt3a binding. These results indicate that Vc facilitates Dppa3 transcription during early stages of reprogramming leading to the initiation of maturation process, binding of Dppa3 to the Dlk1-Dio3 cluster and restriction of Dnmt3a access to this locus.
Discussion
By identifying Dppa3 expression in lg-iPSCs (Gtl2 off ) and hg-iPSCs (Gtl2 on ), but not in pre-iPSCs, we hypothesized that the temporal expression of Dppa3 is crucial for the maintenance of Dlk1-Dio3 imprinting in lg-iPSCs. This assumption was supported by our observation that Dppa3-KO fibroblasts undergoing reprogramming were arrested in pre-iPSCs state and that the addition of Vc to these pre-iPSCs can only convert them to lgiPSCs, which show abnormal Dlk1-Dio3 imprinting. Further, we identified that in the absence of Dppa3, the ERVs as well as exogenous retrovirus-mediated reprogramming factors remain unsilenced leading to maturation-to-stabilization transition failure. Collectively, our results reveal that the temporal expression of Dppa3 is crucial not only for maintaining the Dlk1-Dio3 imprinting, but also for transition from pre-iPSC-to-lg-iPSC and to establish the authentic induced pluripotency. Dppa3 is highly expressed during embryonic development, as well as in germ cells and pluripotent stem cells 30, 31 . Gene ablation studies of Dppa3 in mice revealed that it functions during early embryonic development to protect the maternal genome against the first wave of active DNA demethylation 26 . Moreover, Dppa3 was also shown to be essential for protecting several but not all imprinted loci and ERVs against DNA demethylation during post-fertilization events 26 . Interestingly, the paternally methylated Dlk1-Dio3 region was not affected in Dppa3-null fertilized oocytes, whereas H19 and Rasgrf1, the two other paternally methylated imprinted loci, showed partial loss of imprints 26 . Similarly, our current analysis of Dppa3-deficient ESCs also revealed no obvious defects in Dlk1-Dio3 imprinting. In contrast to these observations, Dppa3-deficient fibroblasts failed to reprogram, arrested in pre-iPSCs state and showed imprinting defect at the Dlk1-Dio3 cluster. This discrepancy could be mainly due to artificial reprogramming of somatic cells versus normal early embryonic development. Another explanation would be that the oocyte-delivered Dppa3 might maintain stable Dlk1-Dio3 imprinting in Dppa3 À / À embryos and ESCs derived thereof. Supporting this view, imprinting of paternally methylated H19 and Rasgrf1 is markedly disturbed in ESCs derived from Dppa3 À / À embryos, whereas the Dlk1-Dio3 imprinting is stable and normal.
A recent report described that Dppa3 binds to nucleosomes containing an H3K9me2 32 . Our ChIP analysis showed that Dppa3 binds to a specific region in the Dlk1-Dio3 IG-DMR, which also suggests that the interaction might involve modified histones. Unlike many imprinted loci, the IG-DMR of the Dlk1-Dio3 cluster was reported to contain negligible H3K9me2 (ref. 32). Thus, it is possible that the association of Dppa3 with the IG-DMR is mediated by histone modifications other than H3K9me2 or another interaction protein.
Recently, Stadtfeld et al. 10 showed that Vc can prevent the Dlk1-Dio3 imprinting defect during reprogramming mainly by Anti-Oct3/4 2.5 preserving the active chromatin structure at this locus. The resulting active chromatin was suggested to counteract the recruitment of Dnmt3a, a de novo DNA methyltransferase, to this locus thus maintaining the normal imprinting in Vc-treated cells 10 . Our results are in consistent with observations of Stadtfeld et al. 10 , indicating that Vc enhances reprogramming kinetics and prevents Dlk1-Dio3 imprinting loss. Moreover, the comparison of reprogramming kinetics between Vc and OSKM þ D showed that Vc treatment resulted in appearance of iPSC colonies at least 2 days earlier than with OSKM þ D, indicating that Vc broadly impacts reprogramming. Recently, it was reported also that culturing of pre-iPSCs in the presence of Vc establishes chimera forming iPSCs; however, germline transmission and Dlk1-Dio3 imprinting status have not been tested 4 . We observed that although Vc can overcome the pre-iPSCs arrest of Dppa3-KO cells and result in lg-iPSCs establishment, it could not establish the normal imprinting at Dlk1-Dio3 locus. These results highlight that Vc-mediated chromatin changes or gene expression during early stages of reprogramming are crucial for maintenance of Dlk1-Dio3 imprinting.
Dppa3's role in preventing the Dlk1-Dio3 imprinting defect suggests that Vc functions through Dppa3 activation, or Vc and Dppa3 function independently in a similar mechanistic pathway. The former cooperative model is supported by the observation that Dppa3 transcripts are upregulated in Vc-treated cells. The acceleration and efficiency of reprogramming seen with Vc 4,10,33 is also observed with exogenous Dppa3, indicating that Dppa3 either alone or in cooperation with other yet unknown factor(s) might implement Vc-mediated maintenance of Dlk1-Dio3 imprinting. Moreover, the early Dppa3 expression is crucial for ARTICLE timely suppression of virus-mediated reprogramming factors and transition of pre-iPSC into lg-iPSC state. On the basis of our observations, we propose that early Dppa3 expression, by exogenous induction or Vc exposure, is followed by Dppa3 binding to the IG-DMR and probably to other genomic regions. Bound Dppa3 prevents Dnmt3a recruitment to the IG-DMR, maintaining the imprinting and expression of imprinted Dlk1-Dio3 genes. In line with this hypothesis, it was recently shown that the forced expression of Dppa3 in NIH3T3 cells causes the global DNA demethylation by counteracting the recruitment of Dnmt1, a maintenance DNA methyltransferase 34 . The observed counteracting mechanism was partially mediated by Dppa3 competing for the interaction with Uhrf1/Np95, a protein known to recruit Dnmt1 to hemimethylated DNA and to maintain the DNA methylation during replication [34] [35] [36] . Considering these above observations along with the fact that de novo DNA methylation process requires cooperation between Dnmt3a and Dnmt1 enzymes 37 , we suggest that Dppa3 is functioning in a similar way to block the accession of Dnmt3a to Dlk1-Dio3 locus during somatic reprogramming. In the second scenario, the function of Dppa3 is compensated by other Dppa family members or unknown factors, which also implement Vc-mediated imprinting maintenance.
Methods
Cell culture. Mouse ESCs and induced pluripotent stem cells (iPSCs) were cultured in Dulbecco's Modified Eagle Medium (DMEM) (PAN, Germany) supplemented with 15% foetal calf serum (FCS; PAN), 2 mM L-glutamine (PAN), 50 mM b-mercaptoethanol (Gibco/Life Technologies), 1% non-essential amino acids (NEAA) (Gibco/Life Technologies), 1% sodium pyruvate (Gibco/Life Technologies), 1% penicillin/streptomycin (PAN), and 1,000 U ml À 1 leukemia inhibitory factor (LIF) (Millipore, Germany). For reprogramming studies with low-serum medium, cells were cultured in StemPro medium (Invitrogen/Life Technologies) supplemented with StemPro supplement (Invitrogen/Life Technologies), 1% FCS, 2 mM L-Glutamine, 1 mM sodium pyruvate, 1% NEAA, 100 mM b-mercaptoethanol and 1000 U ml À 1 LIF in the presence or absence of 50 mg ml À 1 vitamin C (Sigma-Aldrich).
Preparation of Dppa3-KO/Oct4-EGFP fibroblasts (MEFs). Dppa3-KO mice were generated using the conventional knockout strategy, and were maintained in a 129/Sv and C57BL/6 mixed background 26 . Oct4-EGFP transgenic mice were maintained in a DBA2 and C57BL/6 mixed background 38 . The animals were cared for in accordance with the guidelines of Osaka University Animal Care and Use Committee. To prepare Dppa3-KO/Oct4-EGFP MEFs, Dppa3 À / À male mice carrying the Oct4-EGFP transgene were crossed with Dppa3 þ / À female mice carrying the Oct4-EGFP transgene. The morning on which a copulation plug was noted was defined as embryonic day 0.5 (E0.5). MEFs were isolated from E13.5 embryos. After the removal of the head, visceral tissues and gonads, the remaining bodies were washed with phosphate-buffered saline, minced and dissociated with 0.1% Trypsin/ 1mM EDTA solution. MEFs from each embryo were plated on individual 0.1% gelatin-coated 100 mm dishes and incubated at 37°C with 5% CO 2 . We used the MEFs within two passages from initial plating to avoid replicative senescence. The embryo heads were used for genotyping Dppa3 as described previously 26 . The sex of the embyros and the presence of the Oct4-EGFP transgene were determined by morphology and EGFP fluorescence of gonads, respectively. Dppa3-KO MEFs preparations were approved by Osaka University Animal Care and Use Committee.
Generation of iPSCs. We used retroviral expression vectors for Oct3/4, Sox2, Klf4 and c-Myc either in presence or absence of Dppa3 (ref.
3) to reprogram MEFs into iPSCs. Briefly, MEFs isolated from transgenic Nanog-EGFP mice 39 or Dppa3-KO/Oct4-EGFP mice were transduced with retroviral particles as described 27 . To establish iPSC lines, colonies appearing 8-12 days after transduction were selected and cultured in 24-well plates under standard ESC culture conditions and monitored for ESC-like morphology using an Olympus IX71 inverted microscope (Olympus). Further, several independent iPSC lines were established from each combination to examine the expression of Gtl2, as well as for further characterization. Alternatively, iPSCs were generated in low-serum medium, as described above.
Immunostaining and alkaline phosphatase (AP) staining. Immunostaining was performed as described previously 40 using mouse monoclonal antibodies to SSEA1. Cytochemical staining for AP was performed using the Leukocyte Alkaline Phosphatase Kit (Sigma-Aldrich).
Total protein extraction and western blotting. Total protein extracts were prepared using lysis buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 2.5% SDS, 100 mM phenylmethylsulfonyl fluoride (PMSF)) containing protease inhibitor cocktail (Roche). Protein samples were resolved on 4-12% SDS-PAGE gels (Life Technologies) and transferred onto nitrocellulose membranes (Amersham Biosciences/GE Healthcare). Membranes were processed using standard western blot protocols, and signals were detected using a chemiluminescence kit (Santa Cruz Biotechnology). Antibody sources are listed in Supplementary Table 1 .
RNA extraction and real-time PCR (qRT-PCR) analysis. Total RNA was extracted from cells using NucleoSpin miRNA kit (Machery-Nagel) following the manufacturer's protocols. For the mRNA quantification experiment, 5 mg total RNA was converted into complementary DNA (cDNA) using the SuperScript II System (Invitrogen/Life Technologies). For the miRNA quantification experiment, 1 mg total RNA was used for cDNA synthesis using the miScript II RT Kit (Qiagen).
For qRT-PCR analysis, diluted cDNA (1/10) was used as a template in QuantiFast SYBR Green (Qiagen) assays on an ABI7900HT Real-Time PCR System (Applied Biosystems). The qRT-PCR data were normalized to the expression of housekeeping genes (Hprt and Gapdh) and presented as percent expression of the mean of the two housekeeping genes. Primers used in qRT-PCR are listed in Supplementary Table 2 .
Bisulfite sequence analysis. WT or Dppa3-KO ES cells were bisulfite-treated using the EpiTect Bisulfite Kit (Qiagen). To amplify the DMRs of H19, Dlk1/Gtl2 and Rasgrf1, fully or seminested PCR was performed. The first and second rounds of PCR were performed using AccuPrime Taq DNA polymerase (Invitrogen) and ExTaq HS (Takara Bio), respectively. The first round of PCR consisted of the following cycling conditions: 2 min at 94°C for 1 cycle and 30 s at 94°C, 30 s at 50°C and 1 min at 68°C for 30 cycles. The second round of PCR consisted of the following cycling conditions: 2 min at 94°C for 1 cycle and 30 s at 94°C, 30 s at 55°C and 1 min at 72°C for 30 cycles. The sequences of the PCR primers have been described previously 26 . The PCR products were purified using the QIAEX II Gel Extraction Kit (QIAGEN), cloned into the pGEM-T Vector (Promega) and sequenced using an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems).
Methylation analysis of the Gtl2 IG-DMR. Genomic DNA isolation from cells and bisulfite pyrosequencing were performed as previously described 41 . Briefly, Genomic DNA of MEFs, iPSCs and ESCs was extracted with the GentraPuregeneKit (Qiagen) according to the manufacturer's instructions and quantified using a NanoDrop 2000 spectrophotometer. Bisulfite conversion of 500 ng genomic DNA per sample was performed with the EpiTect Bisulfite Kit (Qiagen) according to the manufacturer's specifications. Quantification of DNA methylation was carried out by PCR of Bisulfite-converted DNA and pyrosequencing. PCR and sequencing primers for bisulfite pyrosequencing were designed using the Pyrosequencing Assay Design Software 2.0 (Qiagen) and are listed in Supplementary Table 2 . For pyrosequencing, a PyroMark Q96 ID instrument (Qiagen) and PyroMark Gold Q96 reagents (Qiagen) were used. Data were analysed using the PyroMark CpG Software 1.0.11 (Qiagen).
Chromatin immunoprecipitation (ChIP) assay. ChIP assays were performed on ESCs and MEFs undergoing reprogramming using the Diagenode OneDay ChIP kit (Diagenode). Briefly, the cells (3 Â 10 6 cells per pull-down) were crosslinked using formaldehyde and lysed using the shearing kit (Diagenode), followed by sonication with a bioruptor (Diagenode, UCD-200 TM) to obtain an average chromatin size of 400 bp. Then, the sheared chromatin was immunoprecipitated with 5 mg of indicated antibodies, and the Diagenode OneDay ChIP protocol was followed to extract the chromatin bound to each specific antibody. Rabbit IgG was used as a control in mock ChIP experiments. Quantitative analysis was performed using qRT-PCR and the primers listed in Supplementary Table 2 . The ChIP-qPCR data were analysed using DCt method in which the immunoprecipitated (IPed) sample Ct value was normalized to the input DNA Ct value and the percentage of precipitation was calculated using the following formula-%input ¼ 2^-(Ct InputCt IPed) Â dilution factor of Input DNA Â 100%. All fold enrichment values are means of three independent experiments.
Teratoma formation assay. The teratoma formation assay was performed as previously described 42, 43 . Briefly, iPSCs (1 Â 10 6 cells) were injected subcutaneously into RAG2 À / À gc À / À mice lacking T, B and natural killer (NK) cells. Tumour growth was monitored weekly by palpation and size was measured using linear calipers. Animals were sacrificed when a tumour diameter of 1 cm was reached. Autopsies were performed and tumour tissue was placed in phosphatebuffered 4% formalin for 16 h and then embedded in paraffin. For histological analysis, the specimens were stained with hematoxylin and eosin (HE).
Replicates. Unless otherwise stated, all results presented are representative of two or more independent experiments. All qRT-PCR data for RNA expression analysis were calculated using either the standard curve method or comparative Ct method.
